BioLife Solutions, Inc. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
BioLife Solutions, Inc. (BLFS) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$2.52 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2018-03-09
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-12-31 was -$557.89K.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-09-30 was -$318.72K.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-06-30 was -$768.21K.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-03-31 was -$870.29K.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2017 was -$2.52M.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2016 was -$8.04M.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was -$4.99M.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was -$3.22M.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | -$557.89K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$876.60K derived: sum of 2 quarters · filed 2018-03-09 | -$1.64M derived: sum of 3 quarters · filed 2018-03-09 | -$2.52M 10-K · filed 2018-03-09 | |
| 2017-09-30 | -$318.72K 10-Q · filed 2017-11-09 | -$1.09M derived: sum of 2 quarters · filed 2017-11-09 | -$1.96M 10-Q · filed 2017-11-09 | -$5.52M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2017-06-30 | -$768.21K 10-Q · filed 2017-08-11 | -$1.64M 10-Q · filed 2017-08-11 | -$5.20M derived: sum of 3 quarters · filed 2018-03-09 | -$6.47M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2017-03-31 | -$870.29K 10-Q · filed 2017-05-12 | -$4.44M derived: sum of 2 quarters · filed 2018-03-09 | -$5.70M derived: sum of 3 quarters · filed 2018-03-09 | -$7.42M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-12-31 | -$3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$4.83M derived: sum of 2 quarters · filed 2018-03-09 | -$6.55M derived: sum of 3 quarters · filed 2018-03-09 | -$8.04M 10-K · filed 2018-03-09 | |
| 2016-09-30 | -$1.27M 10-Q · filed 2017-11-09 | -$2.99M derived: sum of 2 quarters · filed 2017-11-09 | -$4.48M 10-Q · filed 2017-11-09 | -$5.88M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | -$1.72M 10-Q · filed 2017-08-11 | -$3.21M 10-Q · filed 2017-08-11 | -$4.61M derived: sum of 3 quarters · filed 2017-08-11 | -$5.90M derived: sum of 4 quarters · filed 2017-08-11 | |
| 2016-03-31 | -$1.49M 10-Q · filed 2017-05-12 | -$2.89M derived: sum of 2 quarters · filed 2017-05-12 | -$4.18M derived: sum of 3 quarters · filed 2017-05-12 | -$5.33M derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$2.69M derived: sum of 2 quarters · filed 2017-03-15 | -$3.84M derived: sum of 3 quarters · filed 2017-03-15 | -$4.99M 10-K · filed 2017-03-15 | -$4.21M 10-K · filed 2016-02-25 |
| 2015-09-30 | -$1.29M 10-Q · filed 2016-11-10 | -$2.44M derived: sum of 2 quarters · filed 2016-11-10 | -$3.59M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$1.15M 10-Q · filed 2016-08-11 | -$2.30M 10-Q · filed 2016-08-11 | |||
| 2015-03-31 | -$1.15M 10-Q · filed 2016-05-16 | ||||
| 2014-12-31 | -$3.22M 10-K · filed 2016-02-25 | ||||
| 2013-12-31 | -$1.08M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |